Search

everythinglearnresearchcommunity

for

Search:↓

The review concludes that more research is needed to better improve the health outcomes for people with Polycystic Ovarian Syndrome.

Using finasteride for hair loss or prostate issues does not significantly raise the risk of erectile dysfunction.

Hormonal imbalances are a key cause of missed menstrual periods in women.

The document concludes that accurate diagnosis and management of PCOS are crucial due to its associated health risks.

Hair loss increases with age; alcohol raises risk, more female partners lowers it.

Women with PCOS have more emotional and body image issues than healthy women.

Nandrolone might increase muscle mass with fewer side effects than testosterone but could cause erectile dysfunction and needs more research.

Finasteride can cause sexual dysfunction and depression, which may persist and require hormonal treatment.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Athletes use steroids to enhance performance despite health risks and legal issues, and education on their dangers is needed.

The protein StAR is found in 17 different organs and can affect hair loss and brain functions, but its full role is not yet fully understood.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

People with polycystic ovary syndrome are more likely to have poor sleep, restless legs syndrome, anxiety, and depression.

The herbal extract was found to effectively reduce and prevent hair loss without any side effects.

Some natural remedies may help with hair regrowth, but more research is needed to confirm their effectiveness and safety.

Different ACE2 gene versions may affect COVID-19 impact based on age and suggest some hair loss drugs could be potential treatments.

Women with polycystic ovary syndrome (PCOS) show higher levels of hope, judgement, perspective, and transcendence, and could benefit from positive psychology therapy.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Women with Polycystic Ovary Syndrome (PCOS) often have higher levels of anxiety and depression, especially if they live in rural areas, have less education, don't have children, are over 30, or are obese.

Women with PCOS have a higher chance of experiencing depression, anxiety, and sleep disorders.

Cannabinoids like CBD and THC may help treat non-cancer skin diseases, but more research is needed.

Mice with a virus similar to COVID-19 had skin damage, but a special treatment helped repair it.

Topical treatments like minoxidil and corticosteroids are effective for hair loss, with JAK inhibitors promising for alopecia areata.

Hair loss, prostate size, and urinary issues are related due to androgen effects.

Spironolactone is effective for idiopathic hirsutism but has limited effects on other PCOS symptoms.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Diagnosing PCOS is challenging due to its complex and varied symptoms.

Antiandrogens help treat hormone-related conditions in both men and women.

Studying acne-related syndromes helps us understand acne causes and can lead to new treatments.